Market Overview:
The global CASP7 market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for caspases from biopharmaceutical companies, hospitals, bioscience research institutions, and others. Additionally, the growing awareness about caspases and their applications is also contributing to the growth of this market.
Product Definition:
The cysteine-aspartic acid proteases, or caspases, are a family of enzymes that cleave proteins after the aspartate residue. Caspase 7 is a member of this enzyme family and is involved in apoptosis (programmed cell death).
Above 90%:
The global CASP7 market size was valued at USD 5.5 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. Increasing prevalence of cancer & cardiovascular diseases, rising geriatric population base, increasing healthcare expenditure levels in developing countries are some major factors that are expected to drive the growth of this market during the forecast period.
Increasing demand for advanced diagnostic imaging techniques such as perfusion imaging.
Above 95%:
The Above 95% is a new term in the world of clinical research and pharmaceutical industry. It means that the drug or biologic above 95% efficiency has been tested for its therapeutic effect. The normal process of drug approval by Food and Drug Administration (FDA) requires that a medicine show an improvement over the current standard of care when compared to an established benchmarking therapy, which defines a minimal clinically important difference.
Application Insights:
The biopharmaceutical companies segment dominated the global market in terms of revenue in 2017. This is attributed to the rising usage of caspase 7 inhibitors for treating various life-threatening diseases, such as acute kidney failure, sepsis, and cancer. The Hospitals segment is expected to be the fastest growing application over the forecast period owing to increasing prevalence of chronic diseases and an aging population across regions. For instance, as per WHO estimates Chronic Diseases Atlas 2015-2016; chronic conditions are responsible for around 60% of deaths globally or 6th leading cause of mortality worldwide. Thus growth in this sector is crucial if governments aim at reducing mortality rate from chronic conditions by 2020 as planned by WHO.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biopharmaceutical companies and bioscience research institutes engaged in R&D for cancer, diabetes, and other diseases is one of the major factors contributing to the growth. Moreover, increasing government funding for such projects is also expected to drive regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments by various public & private entities in R&D activities related to disease management & treatment as well as advanced healthcare infrastructure development. In addition, favorable government initiatives pertaining towards promoting medical tourism are further expected boost regional demand during this period.
Growth Factors:
- Increasing demand for protein-based therapeutics: The global market for protein-based therapeutics is expected to grow at a CAGR of 9.5% from 2016 to 2021. This growth can be attributed to the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases. CASP7 is a key enzyme involved in the processing of proteins and is essential for the production of functional proteins. Thus, its use in therapeutic applications is likely to drive its demand in the coming years.
- Growing popularity of CRISPR technology: CRISPR (clustered regularly interspaced short palindromic repeats) technology has gained immense popularity in recent years due to its ability to edit genes with high precision and efficiency. This has led to an increase in research activities focused on using CRISPR technology for gene therapy and other biomedical applications. CASP7 plays an important role in guiding CRISPR complexes towards their target genes, making it an essential component of this technology platform. As such, the growing adoption of CRISPR technology is likely to boost demand for CASP7 globally over the next few years
Scope Of The Report
Report Attributes
Report Details
Report Title
CASP7 Market Research Report
By Type
Above 90%, Above 95%, Above 99%, Others
By Application
Biopharmaceutical Companies, Hospitals, Bioscience Research Institutions, Others
By Companies
Abbexa Ltd(UK), Abiocode(US), Aviva Systems Biology Corporation(US), Boster Biological Technology(USA), Biobyt(UK), Bio-Rad(US), Bioss Antibodies(US), BioVision(US), BioLegend(US), Epigentek(US), EnzoLifeSciences(CH), Lifespan Biosciences(US), MBL(US), Novus Biologicals(US), ProSci(US), ProteoGenix(FR), Rockland(US), R&D Systems(US), St John's Laboratory Ltd(UK), Thermo Fisher Scientific(US), USBiological(US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global CASP7 Market Report Segments:
The global CASP7 market is segmented on the basis of:
Types
Above 90%, Above 95%, Above 99%, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, Hospitals, Bioscience Research Institutions, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbexa Ltd(UK)
- Abiocode(US)
- Aviva Systems Biology Corporation(US)
- Boster Biological Technology(USA)
- Biobyt(UK)
- Bio-Rad(US)
- Bioss Antibodies(US)
- BioVision(US)
- BioLegend(US)
- Epigentek(US)
- EnzoLifeSciences(CH)
- Lifespan Biosciences(US)
- MBL(US)
- Novus Biologicals(US)
- ProSci(US)
- ProteoGenix(FR)
- Rockland(US)
- R&D Systems(US)
- St John's Laboratory Ltd(UK)
- Thermo Fisher Scientific(US)
- USBiological(US)
Highlights of The CASP7 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Above 90%
- Above 95%
- Above 99%
- Others
- By Application:
- Biopharmaceutical Companies
- Hospitals
- Bioscience Research Institutions
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the CASP7 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
CASP7 is a protein that in humans is encoded by the CASP7 gene. CASP7 belongs to the Caspase family of proteins, which are involved in apoptosis or programmed cell death. The CASP7 protein mediates the execution of apoptotic programs by cleaving and activating caspases, leading to cell death.
Some of the key players operating in the casp7 market are Abbexa Ltd(UK), Abiocode(US), Aviva Systems Biology Corporation(US), Boster Biological Technology(USA), Biobyt(UK), Bio-Rad(US), Bioss Antibodies(US), BioVision(US), BioLegend(US), Epigentek(US), EnzoLifeSciences(CH), Lifespan Biosciences(US), MBL(US), Novus Biologicals(US), ProSci(US), ProteoGenix(FR), Rockland(US), R&D Systems(US), St John's Laboratory Ltd(UK), Thermo Fisher Scientific(US), USBiological(US).
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. CASP7 Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. CASP7 Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. CASP7 Market - Supply Chain
4.5. Global CASP7 Market Forecast
4.5.1. CASP7 Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. CASP7 Market Size (000 Units) and Y-o-Y Growth
4.5.3. CASP7 Market Absolute $ Opportunity
5. Global CASP7 Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. CASP7 Market Size and Volume Forecast by Type
5.3.1. Above 90%
5.3.2. Above 95%
5.3.3. Above 99%
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global CASP7 Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. CASP7 Market Size and Volume Forecast by Application
6.3.1. Biopharmaceutical Companies
6.3.2. Hospitals
6.3.3. Bioscience Research Institutions
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global CASP7 Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. CASP7 Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global CASP7 Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. CASP7 Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global CASP7 Demand Share Forecast, 2019-2026
9. North America CASP7 Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America CASP7 Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America CASP7 Market Size and Volume Forecast by Application
9.4.1. Biopharmaceutical Companies
9.4.2. Hospitals
9.4.3. Bioscience Research Institutions
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America CASP7 Market Size and Volume Forecast by Type
9.7.1. Above 90%
9.7.2. Above 95%
9.7.3. Above 99%
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America CASP7 Demand Share Forecast, 2019-2026
10. Latin America CASP7 Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America CASP7 Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America CASP7 Market Size and Volume Forecast by Application
10.4.1. Biopharmaceutical Companies
10.4.2. Hospitals
10.4.3. Bioscience Research Institutions
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America CASP7 Market Size and Volume Forecast by Type
10.7.1. Above 90%
10.7.2. Above 95%
10.7.3. Above 99%
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America CASP7 Demand Share Forecast, 2019-2026
11. Europe CASP7 Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe CASP7 Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe CASP7 Market Size and Volume Forecast by Application
11.4.1. Biopharmaceutical Companies
11.4.2. Hospitals
11.4.3. Bioscience Research Institutions
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe CASP7 Market Size and Volume Forecast by Type
11.7.1. Above 90%
11.7.2. Above 95%
11.7.3. Above 99%
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe CASP7 Demand Share, 2019-2026
12. Asia Pacific CASP7 Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific CASP7 Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific CASP7 Market Size and Volume Forecast by Application
12.4.1. Biopharmaceutical Companies
12.4.2. Hospitals
12.4.3. Bioscience Research Institutions
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific CASP7 Market Size and Volume Forecast by Type
12.7.1. Above 90%
12.7.2. Above 95%
12.7.3. Above 99%
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific CASP7 Demand Share, 2019-2026
13. Middle East & Africa CASP7 Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa CASP7 Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa CASP7 Market Size and Volume Forecast by Application
13.4.1. Biopharmaceutical Companies
13.4.2. Hospitals
13.4.3. Bioscience Research Institutions
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa CASP7 Market Size and Volume Forecast by Type
13.7.1. Above 90%
13.7.2. Above 95%
13.7.3. Above 99%
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa CASP7 Demand Share, 2019-2026
14. Competition Landscape
14.1. Global CASP7 Market: Market Share Analysis
14.2. CASP7 Distributors and Customers
14.3. CASP7 Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbexa Ltd(UK)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abiocode(US)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Aviva Systems Biology Corporation(US)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Boster Biological Technology(USA)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Biobyt(UK)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bio-Rad(US)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bioss Antibodies(US)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. BioVision(US)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. BioLegend(US)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Epigentek(US)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. EnzoLifeSciences(CH)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Lifespan Biosciences(US)
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. MBL(US)
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Novus Biologicals(US)
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. ProSci(US)
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. ProteoGenix(FR)
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Rockland(US)
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. R&D Systems(US)
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. St John's Laboratory Ltd(UK)
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Thermo Fisher Scientific(US)
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
